1. Moving towards personalised therapy in patients with hepatocellular carcinoma: the role of the microenvironment
   Gianluigi Giannelli et al, 2014, Gut CrossRef
2. Genetic and Pharmacological Screens Converge in Identifying FLIP, BCL2, and IAP Proteins as Key Regulators of Sensitivity to the TRAIL-Inducing Anticancer Agent ONC201/TIC10
   Joshua E. Allen et al, 2015, Cancer Research CrossRef
3. Connexin-dependent gap junction enhancement is involved in the synergistic effect of sorafenib and all-trans retinoic acid on HCC growth inhibition
   YAN YANG et al, 2014, Oncology Reports CrossRef
4. Resveratrol sensitizes HepG2 cells to TRAIL-induced apoptosis
   Masahiko Tameda et al, 2014, Anti-Cancer Drugs CrossRef
5. Rocaglamide overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells by attenuating the inhibition of caspase-8 through cellular FLICE-like-inhibitory protein downregulation
   ZHOU LUAN et al, 2015, Molecular Medicine Reports CrossRef
6. Exosomal delivery of TRAIL and miR‑335 for the treatment of hepatocellular carcinoma (Review)
   Nikita Thapa et al, 2022, International Journal of Molecular Medicine CrossRef
7. Bax/Bak-independent mitochondrial depolarization and reactive oxygen species induction by sorafenib overcome resistance to apoptosis in renal cell carcinoma
   Bernhard Gillissen et al, 2017, Journal of Biological Chemistry CrossRef
8. Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma
   Mei-Chuan Chen et al, 2016, Oncotarget CrossRef
9. Effect and safety of sorafenib in patients with intermediate hepatocellular carcinoma who received transarterial chemoembolization: A retrospective comparative study
   Xue-Fen Lei et al, 2018, World Journal of Clinical Cases CrossRef
10. Knockout of ADAM10 enhances sorafenib antitumor activity of hepatocellular carcinoma in vitro and in vivo
    WEI ZHANG et al, 2014, Oncology Reports CrossRef
11. Recent advances in multidisciplinary management of hepatocellular carcinoma
    Asmaa I Gomaa, 2015, World Journal of Hepatology CrossRef
12. Combined Anti-Cancer Effects of Platycodin D and Sorafenib on Androgen-Independent and PTEN-Deficient Prostate Cancer
    Zongliang Lu et al, 2021, Frontiers in Oncology CrossRef